4.3 Review

Will advances in functional renal magnetic resonance imaging translate to the nephrology clinic?

Journal

NEPHROLOGY
Volume 27, Issue 3, Pages 223-230

Publisher

WILEY
DOI: 10.1111/nep.13985

Keywords

acute kidney injury; chronic kidney disease; fibrosis; magnetic resonance imaging; nephrology; perfusion

Funding

  1. Kidney Research UK [KS_IN_002_20180913]

Ask authors/readers for more resources

Functional multi-parametric renal MRI is a noninvasive imaging strategy that can quantify structural and tissue abnormalities of the kidney, potentially playing a crucial role in the diagnosis and treatment of kidney diseases.
Characterizing structural and tissue abnormalities of the kidney is fundamental to understanding kidney disease. Functional multi-parametric renal magnetic resonance imaging (MRI) is a noninvasive imaging strategy whereby several sequences are employed within a single session to quantify renal perfusion, tissue oxygenation, fibrosis, inflammation, and oedema without using ionizing radiation. In this review, we discuss evidence surrounding its use in several clinical settings including acute kidney injury, chronic kidney disease, hypertension, polycystic kidney disease and around renal transplantation. Kidney size on MRI is already a validated measure for making therapeutic decisions in the setting of polycystic kidney disease. Functional MRI sequences, T1 mapping and apparent diffusion coefficient, can non-invasively quantify interstitial fibrosis and so may have a near-future role in the nephrology clinic to stratify the risk of progressive chronic kidney disease or transplant dysfunction. Beyond this, multi-parametric MRI may be used diagnostically, for example differentiating inflammatory versus ischaemic causes of renal dysfunction, but this remains to be proven. Changes in MRI properties of kidney parenchyma may be useful surrogate markers to use as end points in clinical trials to assess if drugs prevent renal fibrosis or alter kidney perfusion. Large, multi-centre studies of functional renal MRI are ongoing which aim to provide definitive answers as to its role in the management of patients with renal dysfunction.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Transplantation

Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease

Alberto Ortiz, Charles J. Ferro, Olga Balafa, Michel Burnier, Robert Ekart, Jean-Michel Halimi, Reinhold Kreutz, Patrick B. Mark, Alexandre Persu, Patrick Rossignol, Luis M. Ruilope, Roland E. Schmieder, Jose M. Valdivielso, Lucia Del Vecchio, Carmine Zoccali, Francesca Mallamaci, Pantelis Sarafidis

Summary: Diabetic kidney disease (DKD) is the most common cause of chronic kidney disease (CKD), with high risks of kidney failure and cardiovascular death for patients with CKD, especially those with diabetes. Renin-angiotensin system (RAS) blockers and sodium-glucose co-transporter-2 inhibitors (SGLT2is) have shown some protective effects, but the risks remain high. Steroidal mineralocorticoid receptor antagonists (MRAs) may provide potential benefits, but safety concerns exist. The FInerenone in reducing kiDnEy faiLure and dIsease prOgression in DKD (FIDELIO-DKD) study has shown promising results for non-steroidal MRA finerenone.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Cardiac & Cardiovascular Systems

High-dose intravenous iron reduces myocardial infarction in patients on haemodialysis

Mark C. Petrie, Pardeep S. Jhund, Eugene Connolly, Patrick B. Mark, Michael R. MacDonald, Michele Robertson, Stefan D. Anker, Sunil Bhandari, Kenneth Farrington, Philip A. Kalra, David C. Wheeler, Charles R. Tomson, Ian Ford, John J. McMurray, Iain C. Macdougall

Summary: This study aimed to investigate the effect of high-dose vs. low-dose intravenous iron on myocardial infarction in patients on maintenance haemodialysis. The results showed that high-dose IV iron reduced myocardial infraction in patients receiving haemodialysis.

CARDIOVASCULAR RESEARCH (2023)

Review Transplantation

The 'other' big complication: how chronic kidney disease impacts on cancer risks and outcomes

Jennifer S. Lees, Benjamin M. P. Elyan, Sandra M. Herrmann, Ninian N. Lang, Robert J. Jones, Patrick B. Mark

Summary: Cancer risk is higher in patients with chronic kidney disease (CKD), especially those with lower estimated glomerular filtration rate (eGFR) or albuminuria. The increased risk of cancer in CKD is influenced by various factors including patient characteristics, disease factors, and treatment factors. Renal adverse events associated with chemotherapy and newer anti-cancer therapies may contribute to worse cancer outcomes in CKD patients. Acknowledging the increased cancer risk in CKD can potentially improve management.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Letter Urology & Nephrology

The impact of Omicron on outcomes following infection with SARS-CoV-2 in patients with kidney failure in Scotland

Samira Bell, Jacqueline Campbell, Chrissie Watters, Martin O'Neil, Alison Almond, Katharine Buck, Edward J. Carr, Zoe Cousland, Mark Findlay, Nicola Joss, Wendy Metcalfe, Elaine Spalding, Shona Methven, Patrick B. Mark

CLINICAL KIDNEY JOURNAL (2023)

Article Transplantation

Bioimpedance in CKD: an untapped resource?

Kaitlin J. Mayne, Jennifer S. Lees, William G. Herrington

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Medicine, General & Internal

Empagliflozin in Patients with Chronic Kidney Disease

William G. Herrington, Natalie Staplin, Christoph Wanner, Jennifer B. Green, Sibylle J. Hauske, Jonathan R. Emberson, David Preiss, Parminder Judge, Kaitlin J. Mayne, Sarah Y. A. Ng, Emily Sammons, Doreen Zhu, Michael Hill, Will Stevens, Karl Wallendszus, Susanne Brenner, Alfred K. Cheung, Zhi-Hong Liu, Jing Li, Lai Seong Hooi, Wen Liu, Takashi Kadowaki, Masaomi Nangaku, Adeera Levin, David Cherney, Aldo P. Maggioni, Roberto Pontremoli, Rajat Deo, Shinya Goto, Xavier Rossello, Katherine R. Tuttle, Dominik Steubl, Michaela Petrini, Dan Massey, Jens Eilbracht, Martina Brueckmann, Martin J. Landray, Colin Baigent, Richard Haynes

Summary: Empagliflozin therapy reduces the risk of disease progression or cardiovascular death in patients with chronic kidney disease.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Article Cardiac & Cardiovascular Systems

Differential Associations of Cystatin C Versus Creatinine-Based Kidney Function With Risks of Cardiovascular Event and Mortality Among South Asian Individuals in the UK Biobank

Debbie C. Chen, Jennifer S. Lees, Kaiwei Lu, Rebecca Scherzer, Elaine Rutherford, Patrick B. Mark, Alka M. Kanaya, Michael G. Shlipak, Michelle M. Estrella

Summary: In a study of 7,738 South Asian individuals without prevalent heart failure or atherosclerotic cardiovascular disease, cystatin C was found to be more accurate than creatinine in identifying patients with chronic kidney disease and significantly associated with cardiovascular disease and mortality risks.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Urology & Nephrology

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: associations with mortality in a haemodialysis cohort

Kaitlin J. Mayne, Jennifer S. Lees, Elaine Rutherford, Peter C. Thomson, Jamie P. Traynor, Vishal Dey, Ninian N. Lang, Patrick B. Mark

Summary: The neutrophil-to-lymphocyte ratio (NLR) is associated with mortality in haemodialysis patients, while the platelet-to-lymphocyte ratio (PLR) has a weaker association. NLR is more strongly associated with cardiovascular death, while PLR is less associated with non-cardiovascular death. In the COVID-19 subpopulation, both NLR and PLR are associated with COVID-19-related death risk.

CLINICAL KIDNEY JOURNAL (2023)

Article Medicine, General & Internal

Cardiorespiratory Optimisation By Arteriovenous fistula Ligation after renal Transplantation (COBALT): study protocol for a multicentre randomised interventional feasibility trial

Veena Surendrakumar, Emma Aitken, Patrick Mark, Reza Motallebzadeh, James Hunter, Aimen Amer, Dominic Summers, Kirsten Rennie, Leila Rooshenas, Madalina Garbi, Karl Sylvester, Cara Hudson, Jennifer Banks, Anna Sidders, Andrew Norton, Matthew Slater, Matthew Bartlett, Simon Knight, Gavin Pettigrew

Summary: Cardiovascular events are a leading cause of death after successful kidney transplantation. This study aims to assess whether recipients with a well-functioning kidney transplant should undergo elective arteriovenous fistula (AVF) ligation, as AVFs may contribute to adverse cardiac remodeling. The study will evaluate patients' physical functioning and quality of life, and the results will be disseminated through academic conferences and peer-reviewed publications.

BMJ OPEN (2023)

Article Cardiac & Cardiovascular Systems

Adjudicated myocarditis and multisystem illness trajectory in healthcare workers post-COVID-19

Robert Sykes, Andrew J. Morrow, Alex McConnachie, Anna Kamdar, C. Bagot, Hannah Bayes, Kevin G. Blyth, Michael Briscoe, Heeraj Bulluck, David Carrick, Colin Church, David Corcoran, C. Delles, Iain Findlay, Vivienne B. Gibson, Lynsey Gillespie, Douglas Grieve, Pauline Hall Barrientos, Antonia Ho, N. N. Lang, David J. Lowe, Vera Lennie, Peter MacFarlane, Kaithlin J. Mayne, Patrick Mark, Alasdair McIntosh, Ross McGeoch, Christopher McGinley, Connor Mckee, Sabrina Nordin, Alexander Payne, Alastair Rankin, Keith E. Robertson, Nicola Ryan, Giles H. Roditi, Naveed Sattar, David B. Stobo, Sarah Allwood-Spiers, Rhian Touyz, Gruschen Veldtman, Sarah Weeden, Stuart Watkins, Paul Welsh, Ryan Wereski, Kenneth Mangion, Colin Berry

Summary: This study investigated the associations of healthcare worker status with multisystem illness trajectory in hospitalized post-COVID-19 individuals. The results showed that healthcare workers had similar age, gender, and cardiovascular risk compared to non-healthcare workers, but had lower acute inflammation, milder illness severity, and shorter duration of hospital admission. Healthcare worker status was independently associated with the likelihood of myocarditis. Healthcare workers also had a higher rate of secondary care referrals.

OPEN HEART (2023)

Article Clinical Neurology

Sex differences in associations between creatinine and cystatin C-based kidney function measures with stroke and major bleeding

Jennifer Susan Lees, Nicole L. De La Mata, Michael K. Sullivan, Melanie L. Wyld, Brenda M. Rosales, Rachel Cutting, James Alan Hedley, Elaine Rutherford, Patrick Barry Mark, Angela C. Webster

Summary: This study aimed to investigate whether adding kidney function biomarkers based on creatinine, cystatin C or a combination of the two could improve risk stratification for stroke and major bleeding, and whether there were sex differences in the additive value of these biomarkers. The results showed that eGFR(Cys) was more strongly associated with ischemic stroke than eGFR(Cr), especially in women. eGFR(Cys) and eGFR(Cr-Cys) were more strongly associated with major bleeding and all-cause mortality than eGFR(Cr) in both men and women. Therefore, enhanced measurement of cystatin C may improve risk stratification and clinical treatment decisions for ischemic stroke and major bleeding, particularly in women.

EUROPEAN STROKE JOURNAL (2023)

Article Cardiac & Cardiovascular Systems

Post-COVID-19 illness and associations with sex and gender

Kenneth Mangion, Andrew J. Morrow, Robert Sykes, Anna Kamdar, Catherine Bagot, George Bruce, Paul Connelly, Christian Delles, Vivienne B. Gibson, Lynsey Gillespie, Pauline Hall Barriento, Vera Lennie, Giles Roditi, Naveed Sattar, David Stobo, Sarah Allwood-Spiers, Alex McConnachie, Colin Berry

Summary: A study found sex differences in myocardial inflammation in female post-COVID-19 patients, who also reported worse outcomes at index admission and 28-60 days follow-up, although they had lower rates of cardiovascular hospitalization.

BMC CARDIOVASCULAR DISORDERS (2023)

Article Oncology

Personalised lung cancer risk stratification and lung cancer screening: do general practice electronic medical records have a role?

Bhautesh Dinesh Jani, Michael K. Sullivan, Peter Hanlon, Barbara I. Nicholl, Jennifer S. Lees, Lamorna Brown, Sara Macdonald, Patrick B. Mark, Frances S. Mair, Frank M. Sullivan

Summary: This study aims to calculate a lung cancer risk score using GP electronic medical records (EMR) for accurate screening of high-risk individuals. By analyzing 2.3 million GP EMR and validating it with 211,597 individuals, the GP-EMR-derived score shows higher accuracy compared to the current lung cancer screening pilot methods.

BRITISH JOURNAL OF CANCER (2023)

Article Medicine, Research & Experimental

The NightLife study - the clinical and cost-effectiveness of thrice-weekly, extended, in-centre nocturnal haemodialysis versus daytime haemodialysis using a mixed methods approach: study protocol for a randomised controlled trial

Katherine L. Hull, Kate Bramham, Cassandra L. Brookes, Victoria Cluley, Carmel Conefrey, Nicola J. Cooper, Helen Eborall, James Fotheringham, Matthew P. M. Graham-Brown, Laura J. Gray, Patrick B. Mark, Sandip Mitra, Gavin J. Murphy, Niamh Quann, Leila Rooshenas, Madeleine Warren, James O. Burton

Summary: The study aims to compare the impact of in-centre nocturnal haemodialysis (INHD) and conventional haemodialysis on the quality of life of chronic kidney disease patients. It is a randomized controlled trial that evaluates the efficacy of both treatments through measures such as dialysis effectiveness, sleep, and cognitive function. Adult patients are eligible to participate in the study.

TRIALS (2023)

No Data Available